Cover Image

Human endogenous retrovirus expression landscape in models of HIV-1 latency

Saved in:

Bibliographic Details
Main Authors:	M. de Mulder Rougvie (Author), G. Beckerle (Author), M. Bendall (Author), L.P. Iniguez (Author), D. Nixon (Author)
Format:	Book
Published:	Elsevier, 2019-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Human endogenous retroviruses in viral disease and therapy
by: Yian Li, et al.
Published: (2022)

Human Endogenous Retrovirus as Therapeutic Targets in Neurologic Disease
by: Karen Giménez-Orenga, et al.
Published: (2021)

Endogenous Retroviruses in Nervous System Disorders
by: Victoria Gröger, et al.
Published: (2021)

Restriction factor expression in HIV-1 vertically-infected children
by: D. Copertino, Jr, et al.
Published: (2019)

Expression of CircRNAs in HIV-1 latently infected cells from an in vitro model
by: L. Iniguez, et al.
Published: (2019)

A zebrafish reporter line reveals immune and neuronal expression of endogenous retrovirus
by: Holly A. Rutherford, et al.
Published: (2022)

Enhanced expression of human endogenous retroviruses in new-onset type 1 diabetes: Potential pathogenetic and therapeutic implications
by: Pier-Angelo Tovo, et al.
Published: (2020)

Ancient origin and complex evolution of porcine endogenous retroviruses
by: Yicong Chen, et al.
Published: (2020)

Bovine trophoblastic cell differentiation and binucleation involves enhanced endogenous retrovirus element expression
by: Koshi Katsuo, et al.
Published: (2012)

Structural variation of centromeric endogenous retroviruses in human populations and their impact on cutaneous T-cell lymphoma, Sézary syndrome, and HIV infection
by: Mark H. Kaplan, et al.
Published: (2019)

The Regulation and Functions of Endogenous Retrovirus in Embryo Development and Stem Cell Differentiation
by: Yangquan Xiang, et al.
Published: (2021)

Nsd2 Represses Endogenous Retrovirus MERVL in Embryonic Stem Cells
by: Tingting Gao, et al.
Published: (2021)

Human Endogenous Retroviruses Are Preferentially Expressed in Mononuclear Cells From Cord Blood Than From Maternal Blood and in the Fetal Part of Placenta
by: Massimiliano Bergallo, et al.
Published: (2020)

Association of Epstein-Barr Virus (EBV) and Human Endogenous Retroviruses (HERV) with Multiple Sclerosis in Northwest of Iran
by: Sara Mafi, et al.
Published: (2023)

Confounding factors in profiling of locus-specific human endogenous retrovirus (HERV) transcript signatures in primary T cells using multi-study-derived datasets
by: Martin V. Hamann, et al.
Published: (2023)

Galectin-1 promotes HIV-1 latency reactivation
by: J. Rubione, et al.
Published: (2019)

Retroviruses, retroelements and their restrictions
by: Atsushi Koito
Published: (2015)

PP 1.41 - 00092 Spatial Transcriptomics and the Search for the Latent HIV-1 Cell Niche
by: D. Dunn, et al.
Published: (2022)

30 Changes in expression of small non-coding RNA during HIV infection and latency in a CD4+ T cell model of HIV latency
by: SaiVikram Vemula, et al.
Published: (2017)

Latency reactivating agents: impact on human macrophages physiology and susceptibility to HIV-1 infection
by: L. Hany, et al.
Published: (2019)

PP 2.7 - 00093 Modeling HIV-1 Pathogenesis and Latency in iPSC-Derived Human Cerebral Organoids
by: J. Crater, et al.
Published: (2022)

Tropism, Cytotoxicity, and Inflammatory Properties of Two Envelope Genes of Murine Leukemia Virus Type-Endogenous Retroviruses of C57BL/6J Mice
by: Young-Kwan Lee, et al.
Published: (2011)

Conference on Retroviruses and Opportunistic Infections
by: Editorial Office
Published: (2007)

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal
by: T.M. Mota, et al.
Published: (2016)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019)

24 Thalidomide reverses latency of HIV-1 provirus
by: S. Samer, et al.
Published: (2016)

HIV-1 transcriptional latency in resting CD4 T-cell
by: M. Benkirane
Published: (2015)

Conference on Retroviruses and Opportunistic Infections 2015
Published: (2015)

HIV latency reversal using designed PKC modulators
by: M.D. Marsden, et al.
Published: (2017)

Induction of HIV from latency by a novel molecule
by: N.M. Archin, et al.
Published: (2015)

Evaluation of HIV latency reversal using designed PKC modulators in humanized BLT mice
by: M.D. Marsden, et al.
Published: (2015)

20 Sirtuin1 inhibitor nicotinamide disrupts HIV-1 latency
by: S. Samer, et al.
Published: (2016)

Mixed effects of HDACi on host gene expression and their implications for HIV reactivation from latency
by: N. Beliakova-Bethell, et al.
Published: (2015)

Combinatorial latency reversal activity of inhibitor of apoptosis antagonists with mechanistically distinct classes of HIV latency reversal agents
by: Shane D. Falcinelli, et al.
Published: (2019)

Allogeneic transplantation following non-myeloablative conditioning in renal carcinoma. New evidence of the immune mechanisms responsible for the activity of this form of immunotherapy and the pathogenetic role of endogenous retroviruses
by: Camillo Porta
Published: (2011)

Allogeneic transplantation following non-myeloablative conditioning in renal carcinoma. New evidence of the immune mechanisms responsible for the activity of this form of immunotherapy and the pathogenetic role of endogenous retroviruses
by: Camillo Porta
Published: (2011)

Integration site-independent enhancement of latency reversal by HIV-1 Nef
by: X.T. Kuang, et al.
Published: (2017)

Effects of aging on regular and express latencies of vergence
by: Qing Yang, et al.
Published: (2009)

Retroviruses: Reversing the dogma of life - A review
by: Shobha Potlakayala, et al.
Published: (2022)

The steroid receptor coactivators are targets for reactivation of HIV latency
by: B.C. Nikolai, et al.
Published: (2015)